Skip to content
  • About Us
    • Our Team
    • Employment Opportunities
    • Hemophilia Advisory Board
    • Cell Therapy Advisory Board
    • MSUD Advisory Board
  • Our Technology
  • Focus
    • Gene Therapy
    • Stem Cell Therapy
  • Our Pipeline
  • Patient Advocacy
    • Gene Therapy Animation
    • Future of hemophilia
    • Dr. Steven Pipe video
    • Dr. Guy Young video
    • Dr. Len Valentino video
    • Dr. Amy Dunn video
    • Patient Education Brochure
    • Expanded Access Policy
  • Our Partners
  • Investors
  • News
    • Company News
    • Publications
    • Industry News
Menu
  • About Us
    • Our Team
    • Employment Opportunities
    • Hemophilia Advisory Board
    • Cell Therapy Advisory Board
    • MSUD Advisory Board
  • Our Technology
  • Focus
    • Gene Therapy
    • Stem Cell Therapy
  • Our Pipeline
  • Patient Advocacy
    • Gene Therapy Animation
    • Future of hemophilia
    • Dr. Steven Pipe video
    • Dr. Guy Young video
    • Dr. Len Valentino video
    • Dr. Amy Dunn video
    • Patient Education Brochure
    • Expanded Access Policy
  • Our Partners
  • Investors
  • News
    • Company News
    • Publications
    • Industry News
  • About Us
    • Our Team
    • Employment Opportunities
    • Hemophilia Advisory Board
    • Cell Therapy Advisory Board
    • MSUD Advisory Board
  • Our Technology
  • Focus
    • Gene Therapy
    • Stem Cell Therapy
  • Our Pipeline
  • Patient Advocacy
    • Gene Therapy Animation
    • Future of hemophilia
    • Dr. Steven Pipe video
    • Dr. Guy Young video
    • Dr. Len Valentino video
    • Dr. Amy Dunn video
    • Patient Education Brochure
    • Expanded Access Policy
  • Our Partners
  • Investors
  • News
    • Company News
    • Publications
    • Industry News
Menu
  • About Us
    • Our Team
    • Employment Opportunities
    • Hemophilia Advisory Board
    • Cell Therapy Advisory Board
    • MSUD Advisory Board
  • Our Technology
  • Focus
    • Gene Therapy
    • Stem Cell Therapy
  • Our Pipeline
  • Patient Advocacy
    • Gene Therapy Animation
    • Future of hemophilia
    • Dr. Steven Pipe video
    • Dr. Guy Young video
    • Dr. Len Valentino video
    • Dr. Amy Dunn video
    • Patient Education Brochure
    • Expanded Access Policy
  • Our Partners
  • Investors
  • News
    • Company News
    • Publications
    • Industry News

Publications

Fetal membrane cells for treatment of steroid-refractory acute graft-versus-host disease

February 18, 2022March 30, 2013 by admin
Categories Decidua Stromal Cells – Cell Therapy, Publications Leave a comment

Liver Transplantation for Classical Maple Syrup Urine Disease: Long-Term Follow-Up in 37 Patients and Comparative United Network for Organ Sharing Experience

February 18, 2022January 22, 2012 by admin
Categories MSUD Gene Therapy, Publications Leave a comment

Enhanced Biosynthesis of Coagulation Factor VIII through Diminished Engagement of the Unfolded Protein Response

February 18, 2022July 5, 2011 by admin
Categories Hemophilia Gene Therapy, Publications Leave a comment

Classical maple syrup urine disease and brain development: Principles of management and formula design

February 18, 2022April 26, 2010 by admin
Categories MSUD Gene Therapy, Publications Leave a comment

Expansion and activation kinetics of immune cells during early phase of GVHD in mouse model based on chemotherapy conditioning

February 18, 2022January 10, 2010 by admin
Categories Decidua Stromal Cells – Cell Therapy, Publications Leave a comment

Identification of Porcine Coagulation Factor VIII Domains Responsible for High Level Expression via Enhanced Secretion

February 18, 2022February 18, 2004 by admin
Categories Hemophilia Gene Therapy, Publications Leave a comment

One Community’s Effort to Control Genetic Disease

February 18, 2022October 11, 2001 by admin
Categories MSUD Gene Therapy, Publications Leave a comment
Newer posts
← Previous Page1 Page2 Page3

Recent Posts

  • Director, Gene and Cell Therapy
  • Challenges and opportunities when transitioning
    from in vivo gene replacement to in vivo CRISPR/
    Cas9 therapies – a spotlight on hemophilia
  • New Agreement Set to Scale Up Production of Hem A Gene Therapy
  • Charles River and ASC Therapeutics to Scale Manufacturing of Second-Generation Gene Therapy for Hemophilia A
  • ASC Therapeutics Joins U.S. Consortium of Gene Therapy Partners Including the NIH and FDA to Accelerate Treatments for Rare Diseases

Recent Comments

No comments to show.

QUICK LINKS

  • About Us
  • Our Pipeline
  • Our Partners
  • Our Technology

Focus

  • Gene Therapy
  • Stem Cell Therapy

NEWS

  • Company News
  • Publications
  • Industry News

Investors

  • Press Release

CONTACT US

  • 888 808 0280
  • info@asctherapeutics.com

Copyright © 2021 ASC Therapeutics